Baicalin shows promise for severe acute pancreatitis

Oct 18 2007

Qingyitang¡, a representative prescription of Traditional Chinese Medicine for SAP was widely used in the orients countries.

But its real pharmacological mechanisms of protective effects on SAP have not been investigated still now. Baicalin, the most effective monomer of Baical skullcap root (an essential Traditional Chinese Medicine of Qingyitang¡), which have been proved a protective effects on renal injury of rats with SAP. The research was recently published on October 14 issue of the World Journal of Gastroenterology because of its great significance for SAP.

It has been confirmed that Baicalin has anti-bacterial, antiviral and anti-inflammatory activities in vitro. It also can inhibit platelet aggregation and eliminate oxygen-free radicals. Animal experiments show that Baicalin could reduce the generation of endotoxin. In addition, Baicalin has potent effect in inhibiting pancreatin which is the initial metabolite of Baicalin. All these pharmacologic actions can inhibit SAP during its multiple stages.

The research team led by Dr. Zhang Xiping from the first people's hospital of Hangzhou and second affiliated hospital of Zhejiang university spent more than five years working with experimental SAP of rats by the intravenous injection of Baicalin treatment. With the large dosage of baicalin treatment, the rats' survival rate, renal function indexes, renal gross changes and lightmicroscopic changes and its severity scores was greatly improved in end. The article clarified that the therapeutic mechanisms might be related to the inhibition of inflammatory mediators and induction of renal cells apoptosis by the application of tissue microarray technique.

Compared with the Octreotide, the most effective drug in the treatment of SAP, the large dosage Baicalin has equally effective as octreotide in terms of reduction of renal pathological alterations of rats with SAP. But for Octreotide, It is difficult to popularize especially in remote areas with poor economy since it features high price, short half-life and inconvenient administration, while Baicalin features low price, extensive routes of administration and preparation, multiple pharmacologic actions and precise therapeutic effects.

So the Baicalin might be a promising therapeutic medicines in the treatment of SAP despite there are still many works to be done future.